| P50 | author | Ismail Gögenur | Q56550094 |
| | Jacob Rosenberg | Q85827214 |
| P2093 | author name string | Russel J Reiter | |
| | Lars Peter Holst Andersen | |
| P2860 | cites work | Phytomelatonin: assisting plants to survive and thrive | Q26824170 |
| | A Phase II, Randomized, Double-Blind, Placebo Controlled, Dose-Response Trial of the Melatonin Effect on the Pain Threshold of Healthy Subjects | Q28533995 |
| | Effects of melatonin treatment in septic newborns. | Q34103557 |
| | Melatonin as a chronobiotic. | Q34384226 |
| | Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort | Q34564079 |
| | Melatonin and melatonergic drugs on sleep: possible mechanisms of action | Q34970081 |
| | Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy | Q35015863 |
| | Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study | Q35597836 |
| | Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity | Q35825510 |
| | Pharmacokinetics of oral and intravenous melatonin in healthy volunteers | Q35928061 |
| | Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial | Q36749111 |
| | Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans | Q36867614 |
| | Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults | Q36928856 |
| | Melatonin in septic shock: some recent concepts | Q37740673 |
| | Potential use of melatonin in sleep and delirium in the critically ill. | Q37993822 |
| | On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. | Q38045452 |
| | A systematic review of peri-operative melatonin. | Q38212332 |
| | Clinical pharmacokinetics of melatonin: a systematic review | Q38501691 |
| | Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients | Q40560062 |
| | Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. | Q42783953 |
| | Pharmacokinetics of orally administered melatonin in critically ill patients | Q43195642 |
| | Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. | Q44426717 |
| | Melatonin reduces oxidative stress in surgical neonates. | Q44766068 |
| | Effects of exogenous melatonin on sleep: a meta-analysis | Q45223376 |
| | Influence of cigarette smoking on melatonin levels in man. | Q46433552 |
| | The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism | Q46587398 |
| | Perioperative melatonin: not ready for prime time. | Q47946527 |
| | Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo-controlled, clinical trial. | Q48318525 |
| | Pharmacokinetics of melatonin in human sexual maturation. | Q51033617 |
| | Pharmacokinetics of melatonin in man: first pass hepatic metabolism. | Q52657201 |
| | Increased bioavailability of oral melatonin after fluvoxamine coadministration. | Q55033613 |
| | Melatonin Reduces Night Blood Pressure in Patients with Nocturnal Hypertension | Q58855300 |
| | Variable bioavailability of oral melatonin | Q73199929 |
| | Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study | Q83903413 |
| | Melatonin identified in meats and other food stuffs: potentially nutritional impact | Q88104682 |
| P433 | issue | 9 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 1027-1030 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy? | |
| P478 | volume | 55 | |